Retrospective comparative study of efficacy, safety and outcome of percutaneous intervention for Budd-Chiari syndrome patients with bilirubin less than 3 and 3-6 mg/dl.

CONCLUSION: Technical success, survival and outcome of percutaneous intervention in BCS patients having serum bilirubin 3-6 mg dl-1 was comparable to patients having bilirubin level <3 mg dl-1.
ADVANCES IN KNOWLEDGE: Percutaneous intervention treatment is suitable for treatment for symptomatic BCS patients having bilirubin up to 6 mg  dl-1.
PMID: 33595338 [PubMed - as supplied by publisher]

Source: The British Journal of Radiology - February 17, 2021 Category: Radiology Authors: Patidar Y, Pal CK, Mukund A, Kumar G, Sarin SK Tags: Br J Radiol Source Type: research